Induced experiments for module 482

Experiment nameClinical attributes
Alizadeh00_DLCL_0005Lymphoma or lymphoma cell line (B lymphoma), Lymphocytes (B lymphoma*), Hematologic cancer and cell line (B lymphoma*), Cancer and cell line (B lymphoma*), B cells (B lymphoma*), Diffuse large B cell lymphoma tumor or cell line (B lymphoma), Hematologic cancer (B lymphoma*), Cancer (B lymphoma*), Diffuse large B cell lymphoma - DLBCL (B lymphoma), Activated B like DLBCL (B lymphoma)
Alizadeh00_DLCL_0014Lymphoma or lymphoma cell line (B lymphoma), Lymphocytes (B lymphoma*), Hematologic cancer and cell line (B lymphoma*), Cancer and cell line (B lymphoma*), B cells (B lymphoma*), Diffuse large B cell lymphoma tumor or cell line (B lymphoma), Hematologic cancer (B lymphoma*), Cancer (B lymphoma*), Diffuse large B cell lymphoma - DLBCL (B lymphoma), Activated B like DLBCL (B lymphoma)
Alizadeh00_DLCL_0019Lymphoma or lymphoma cell line (B lymphoma), Lymphocytes (B lymphoma*), Hematologic cancer and cell line (B lymphoma*), Cancer and cell line (B lymphoma*), B cells (B lymphoma*), Diffuse large B cell lymphoma tumor or cell line (B lymphoma), Hematologic cancer (B lymphoma*), Cancer (B lymphoma*), Diffuse large B cell lymphoma - DLBCL (B lymphoma)
Alizadeh00_DLCL_0025Lymphoma or lymphoma cell line (B lymphoma), Lymphocytes (B lymphoma*), Hematologic cancer and cell line (B lymphoma*), Cancer and cell line (B lymphoma*), B cells (B lymphoma*), Diffuse large B cell lymphoma tumor or cell line (B lymphoma), Hematologic cancer (B lymphoma*), Cancer (B lymphoma*), Diffuse large B cell lymphoma - DLBCL (B lymphoma), Activated B like DLBCL (B lymphoma)
Alizadeh00_DLCL_0035Lymphoma or lymphoma cell line (B lymphoma), Lymphocytes (B lymphoma*), Hematologic cancer and cell line (B lymphoma*), Cancer and cell line (B lymphoma*), B cells (B lymphoma*), Diffuse large B cell lymphoma tumor or cell line (B lymphoma), Hematologic cancer (B lymphoma*), Cancer (B lymphoma*), Diffuse large B cell lymphoma - DLBCL (B lymphoma)
Bhattacharjee01_SQ-1174-A317-5Cancer (Lung cancer*), Cancer and cell line (Lung cancer*), Lung tissue, cancer or cell line (Lung cancer*), Lung cancer (Lung cancer*), Non small cell lung cancer (Lung cancer*), Lung cancer or cell line (Lung cancer*), Non small cell lung cancer and cell line (Lung cancer*), Squamous cell lung cancer (Lung cancer)
Boldrick02_Dose_Response_Dataset_Bp_LPS_0_01ug_ml_timecourse_0_5hrLymphocytes (Stimulated PBMC*), Monocytes (Stimulated PBMC*), Primary blood mononuclear cells (Stimulated PBMC*), Stimulated immune cells (Stimulated PBMC*), Hematologic samples (Stimulated PBMC*), Hematologic samples and cell lines (Stimulated PBMC*), 0.5hr immune stimulation (Stimulated PBMC), Lipopolysaccharide (LPS) stimulated immune cells (Stimulated PBMC), 1X dose immune stimulation (Stimulated PBMC)
Boldrick02_Dose_Response_Dataset_S_aureus_10X_dose_timecourse_4_0hrLymphocytes (Stimulated PBMC*), Monocytes (Stimulated PBMC*), Primary blood mononuclear cells (Stimulated PBMC*), Stimulated immune cells (Stimulated PBMC*), Hematologic samples (Stimulated PBMC*), Hematologic samples and cell lines (Stimulated PBMC*), S. aureus stimulated immune cells (Stimulated PBMC)
Boldrick02_Dose_Response_Dataset_Untreated_timecourse_1_0hrLymphocytes (Stimulated PBMC*), Monocytes (Stimulated PBMC*), Primary blood mononuclear cells (Stimulated PBMC*), Hematologic samples (Stimulated PBMC*), Hematologic samples and cell lines (Stimulated PBMC*), Unstimulated immune cells (Stimulated PBMC)
Garber01_219_97_SCCCancer (Lung cancer*), Cancer and cell line (Lung cancer*), Lung tissue, cancer or cell line (Lung cancer*), Lung cancer (Lung cancer*), Non small cell lung cancer (Lung cancer*), Lung cancer or cell line (Lung cancer*), Non small cell lung cancer and cell line (Lung cancer*), Squamous cell lung cancer (Lung cancer)
Perou00_BC206B_AFBreast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), After doxorubicin chemotherapy (Breast cancer), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*)
Ramaswamy01_Tumor__Lung_Adeno_95_I_117Cancer (Various tumors), Adenocarcinoma (Various tumors), Cancer and cell line (Various tumors), Cancer (Various tumors*), Cancer and cell line (Various tumors*), Mesothelioma (Various tumors)
Ross00_786_0_CL9018_RENALFast doubling (20-40) cell lines (NCI60), Cell line (NCI60*), Cancer and cell line (NCI60*), Renal cancer cell line (NCI60), Renal cancer or cell line (NCI60), Renal tissue (NCI60)
Ross00_SF_539_CL12016_CNSFast doubling (20-40) cell lines (NCI60), Cell line (NCI60*), Cancer and cell line (NCI60*)
Ross00_UO_31_CL9004_RENALCell line (NCI60*), Cancer and cell line (NCI60*), Renal cancer cell line (NCI60), Renal cancer or cell line (NCI60), Renal tissue (NCI60)
Ross01_HME31Cell line (NCI60*), Cancer and cell line (NCI60*), Breast cancer cell line (NCI60), Female hormonal cancer cell line (NCI60), Breast cancer or cell line (NCI60), Breast tissue, cancer or cell line (NCI60), Female hormonal tissue, cancer or cell line (NCI60)
Shipp02_DLBC2Hematologic samples and cell lines (B lymphoma), Lymphoma or lymphoma cell line (B lymphoma), Lymphocytes (B lymphoma*), Hematologic cancer and cell line (B lymphoma*), Cancer and cell line (B lymphoma*), B cells (B lymphoma*), Diffuse large B cell lymphoma tumor or cell line (B lymphoma), Hematologic cancer (B lymphoma*), Cancer (B lymphoma*), Diffuse large B cell lymphoma - DLBCL (B lymphoma), Lymphoma (B lymphoma)
Sorlie01_BC116A_BEBreast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Estogen receptor (ER) positive breast cancer (Breast cancer), Wild type p53 tumor (Breast cancer)
Sorlie01_BC121B_BEBreast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Estogen receptor (ER) positive breast cancer (Breast cancer), Wild type p53 tumor (Breast cancer), Dead prognosis (Breast cancer), Grade 3 (Breast cancer), Breast cancer - (prognostic) relapse (Breast cancer)
Sorlie01_BC608B_BEBreast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Estogen receptor (ER) positive breast cancer (Breast cancer), Wild type p53 tumor (Breast cancer), Breast cancer - (prognostic) relapse (Breast cancer)